246 related articles for article (PubMed ID: 30106752)
1. The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease.
McDonald-Hyman C; Muller JT; Loschi M; Thangavelu G; Saha A; Kumari S; Reichenbach DK; Smith MJ; Zhang G; Koehn BH; Lin J; Mitchell JS; Fife BT; Panoskaltsis-Mortari A; Feser CJ; Kirchmeier AK; Osborn MJ; Hippen KL; Kelekar A; Serody JS; Turka LA; Munn DH; Chi H; Neubert TA; Dustin ML; Blazar BR
J Clin Invest; 2018 Oct; 128(10):4604-4621. PubMed ID: 30106752
[TBL] [Abstract][Full Text] [Related]
2. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease.
Tawara I; Shlomchik WD; Jones A; Zou W; Nieves E; Liu C; Toubai T; Duran-Struuck R; Sun Y; Clouthier SG; Evers R; Lowler KP; Levy RB; Reddy P
J Immunol; 2010 Oct; 185(7):3866-72. PubMed ID: 20810991
[TBL] [Abstract][Full Text] [Related]
3. Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models.
Florek M; Sega EI; Leveson-Gower DB; Baker J; Müller AM; Schneidawind D; Meyer E; Negrin RS
Blood; 2014 Sep; 124(11):1832-42. PubMed ID: 25030062
[TBL] [Abstract][Full Text] [Related]
4. Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients.
Yi T; Li X; Yao S; Wang L; Chen Y; Zhao D; Johnston HF; Young JS; Liu H; Todorov I; Forman SJ; Chen L; Zeng D
J Immunol; 2011 Mar; 186(5):2739-49. PubMed ID: 21263067
[TBL] [Abstract][Full Text] [Related]
5. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
[TBL] [Abstract][Full Text] [Related]
6. Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease.
Sugiyama H; Maeda Y; Nishimori H; Yamasuji Y; Matsuoka K; Fujii N; Kondo E; Shinagawa K; Tanaka T; Takeuchi K; Teshima T; Tanimoto M
Biol Blood Marrow Transplant; 2014 Feb; 20(2):183-91. PubMed ID: 24333142
[TBL] [Abstract][Full Text] [Related]
7. CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.
Beres AJ; Haribhai D; Chadwick AC; Gonyo PJ; Williams CB; Drobyski WR
J Immunol; 2012 Jul; 189(1):464-74. PubMed ID: 22649199
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
Young KJ; DuTemple B; Phillips MJ; Zhang L
J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
[TBL] [Abstract][Full Text] [Related]
9. CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease.
Coghill JM; Fowler KA; West ML; Fulton LM; van Deventer H; McKinnon KP; Vincent BG; Lin K; Panoskaltsis-Mortari A; Cook DN; Blazar BR; Serody JS
Blood; 2013 Aug; 122(5):825-36. PubMed ID: 23798714
[TBL] [Abstract][Full Text] [Related]
10. Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses.
Vogtenhuber C; Bucher C; Highfill SL; Koch LK; Goren E; Panoskaltsis-Mortari A; Taylor PA; Farrar MA; Blazar BR
Blood; 2010 Jul; 116(3):466-74. PubMed ID: 20442366
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease.
Le HT; Keslar K; Nguyen QT; Blazar BR; Hamilton BK; Min B
Front Immunol; 2020; 11():181. PubMed ID: 32117306
[TBL] [Abstract][Full Text] [Related]
12. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
[TBL] [Abstract][Full Text] [Related]
13. TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment.
Pierini A; Strober W; Moffett C; Baker J; Nishikii H; Alvarez M; Pan Y; Schneidawind D; Meyer E; Negrin RS
Blood; 2016 Aug; 128(6):866-71. PubMed ID: 27365424
[TBL] [Abstract][Full Text] [Related]
14. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease.
Mavers M; Simonetta F; Nishikii H; Ribado JV; Maas-Bauer K; Alvarez M; Hirai T; Turkoz M; Baker J; Negrin RS
Front Immunol; 2019; 10():1624. PubMed ID: 31379829
[TBL] [Abstract][Full Text] [Related]
15. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
[TBL] [Abstract][Full Text] [Related]
16. IL-17 gene ablation does not impact Treg-mediated suppression of graft-versus-host disease after bone marrow transplantation.
Colonna L; Florek M; Leveson-Gower DB; Sega EI; Baker J; Smith AT; Negrin RS
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1557-65. PubMed ID: 23921175
[TBL] [Abstract][Full Text] [Related]
17. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
18. Donor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease.
Tawara I; Sun Y; Liu C; Toubai T; Nieves E; Evers R; Alrubaie M; Mathewson N; Tamaki H; Reddy P
J Leukoc Biol; 2012 Apr; 91(4):667-75. PubMed ID: 22262800
[TBL] [Abstract][Full Text] [Related]
19. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
Front Immunol; 2018; 9():3104. PubMed ID: 30733722
[TBL] [Abstract][Full Text] [Related]
20. Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression.
Wachsmuth LP; Patterson MT; Eckhaus MA; Venzon DJ; Gress RE; Kanakry CG
J Clin Invest; 2019 Mar; 129(6):2357-2373. PubMed ID: 30913039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
